-
Could ViroPharma Benefit from Multiple Generic Versions of VANCOCIN?
Wednesday, April 11, 2012 - 12:28pmYesterday morning, the US Food and Drug Administration approved three drug manufacturers' generic versions of ViroPharma's (NASDAQ: VPHM) VANCOCIN HCl capsules. According to Watson Pharmaceuticals' (NYSE: WPI) statment, VANCOCIN is indicated for the treatment of C. difficile-associated diarrhea and...
Read More >>


